{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:43:50Z","timestamp":1792122230768,"version":"4.4.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Current available vaccines for COVID-19 are effective in reducing severe diseases and deaths caused by SARS-CoV-2 infection but less optimal in preventing infection. Next-generation vaccines which are able to induce mucosal immunity in the upper respiratory to prevent or reduce infections caused by highly transmissible variants of SARS-CoV-2 are urgently needed. We have developed an intranasal vaccine candidate based on a live attenuated influenza virus (LAIV) with a deleted NS1 gene that encodes cell surface expression of the receptor-binding-domain (RBD) of the SARS-CoV-2 spike protein, designated DelNS1-RBD4N-DAF. Immune responses and protection against virus challenge following intranasal administration of DelNS1-RBD4N-DAF vaccines were analyzed in mice and compared with intramuscular injection of the BioNTech BNT162b2 mRNA vaccine in hamsters. DelNS1-RBD4N-DAF LAIVs induced high levels of neutralizing antibodies against various SARS-CoV-2 variants in mice and hamsters and stimulated robust T cell responses in mice. Notably, vaccination with DelNS1-RBD4N-DAF LAIVs, but not BNT162b2 mRNA, prevented replication of SARS-CoV-2 variants, including Delta and Omicron BA.2, in the respiratory tissues of animals. The DelNS1-RBD4N-DAF LAIV system warrants further evaluation in humans for the control of SARS-CoV-2 transmission and, more significantly, for creating dual function vaccines against both influenza and COVID-19 for use in annual vaccination strategies.<\/jats:p>","DOI":"10.1038\/s41467-023-37697-1","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T10:04:16Z","timestamp":1681293856000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamsters"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7269-393X","authenticated-orcid":false,"given":"Shaofeng","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel Chun-Yee","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5087-3614","authenticated-orcid":false,"given":"Anna Jinxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobo Wing-Yee","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6194-7885","authenticated-orcid":false,"given":"Teng","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Kukic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0165-7894","authenticated-orcid":false,"given":"Wenjun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6336-6657","authenticated-orcid":false,"given":"Jasper Fuk-Woo","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1921-5824","authenticated-orcid":false,"given":"Kelvin Kai-Wang","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4511-2888","authenticated-orcid":false,"given":"Zhiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2083-1552","authenticated-orcid":false,"given":"Kwok-Yung","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0745-1130","authenticated-orcid":false,"given":"Pui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5108-8338","authenticated-orcid":false,"given":"Honglin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"key":"37697_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270\u2013273 (2020).","journal-title":"Nature"},{"key":"37697_CR2","doi-asserted-by":"publisher","first-page":"o1144","DOI":"10.1136\/bmj.o1144","volume":"377","author":"L Taylor","year":"2022","unstructured":"Taylor, L. Covid-19: True global death toll from pandemic is almost 15 million, says WHO. BMJ 377, o1144 (2022).","journal-title":"BMJ"},{"key":"37697_CR3","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1126\/science.abn1755","volume":"375","author":"DM Altmann","year":"2022","unstructured":"Altmann, D. M. & Boyton, R. J. COVID-19 vaccination: the road ahead. Science 375, 1127\u20131132 (2022).","journal-title":"Science"},{"key":"37697_CR4","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.chom.2021.06.016","volume":"29","author":"K Subbarao","year":"2021","unstructured":"Subbarao, K. The success of SARS-CoV-2 vaccines and challenges ahead. Cell Host Microbe 29, 1111\u20131123 (2021).","journal-title":"Cell Host Microbe"},{"key":"37697_CR5","doi-asserted-by":"publisher","first-page":"eabn4947","DOI":"10.1126\/science.abn4947","volume":"376","author":"JRC Pulliam","year":"2022","unstructured":"Pulliam, J. R. C. et al. Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. Science 376, eabn4947 (2022).","journal-title":"Science"},{"key":"37697_CR6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0140-6736(22)00017-4","volume":"399","author":"N Wolter","year":"2022","unstructured":"Wolter, N. et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet 399, 437\u2013446 (2022).","journal-title":"Lancet"},{"key":"37697_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S1473-3099(22)00733-2","volume":"23","author":"P Arora","year":"2022","unstructured":"Arora, P. et al. Omicron sublineage BQ.1.1 resistance to monoclonal antibodies. Lancet Infect Dis. 23, 22\u201323 (2022).","journal-title":"Lancet Infect Dis."},{"key":"37697_CR8","doi-asserted-by":"publisher","first-page":"104270","DOI":"10.1016\/j.ebiom.2022.104270","volume":"84","author":"A Aggarwal","year":"2022","unstructured":"Aggarwal, A. et al. SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern. EBioMedicine 84, 104270 (2022).","journal-title":"EBioMedicine"},{"key":"37697_CR9","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0140-6736(22)00462-7","volume":"399","author":"T Nyberg","year":"2022","unstructured":"Nyberg, T. et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet 399, 1303\u20131312 (2022).","journal-title":"Lancet"},{"key":"37697_CR10","doi-asserted-by":"publisher","first-page":"288","DOI":"10.46234\/ccdcw2022.071","volume":"4","author":"DJ Smith","year":"2022","unstructured":"Smith, D. J. et al. COVID-19 mortality and vaccine coverage\u2014Hong Kong Special Administrative Region, China, January 6, 2022-March 21, 2022. China CDC Wkly 4, 288\u2013292 (2022).","journal-title":"China CDC Wkly"},{"key":"37697_CR11","doi-asserted-by":"publisher","first-page":"109400","DOI":"10.1016\/j.celrep.2021.109400","volume":"36","author":"TL Bricker","year":"2021","unstructured":"Bricker, T. L. et al. A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters. Cell Rep. 36, 109400 (2021).","journal-title":"Cell Rep."},{"key":"37697_CR12","doi-asserted-by":"publisher","first-page":"e2202069119","DOI":"10.1073\/pnas.2202069119","volume":"119","author":"JL Americo","year":"2022","unstructured":"Americo, J. L., Cotter, C. A., Earl, P. L., Liu, R. & Moss, B. Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection. Proc Natl Acad. Sci USA 119, e2202069119 (2022).","journal-title":"Proc Natl Acad. Sci USA"},{"key":"37697_CR13","doi-asserted-by":"publisher","first-page":"eabj5129","DOI":"10.1126\/sciimmunol.abj5129","volume":"6","author":"JE Oh","year":"2021","unstructured":"Oh, J. E. et al. Intranasal priming induces local lung-resident B cell populations that secrete protective mucosal antiviral IgA. Sci. Immunol. 6, eabj5129 (2021).","journal-title":"Sci. Immunol."},{"key":"37697_CR14","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.scib.2022.05.018","volume":"67","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2. Sci. Bull. (Beijing) 67, 1372\u20131387 (2022).","journal-title":"Sci. Bull. (Beijing)"},{"key":"37697_CR15","doi-asserted-by":"publisher","first-page":"eabo2523","DOI":"10.1126\/science.abo2523","volume":"378","author":"T Mao","year":"2022","unstructured":"Mao, T. et al. Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses. Science 378, eabo2523 (2022).","journal-title":"Science"},{"key":"37697_CR16","doi-asserted-by":"publisher","first-page":"e02180","DOI":"10.1128\/mBio.02180-19","volume":"10","author":"P Wang","year":"2019","unstructured":"Wang, P. et al. Generation of DelNS1 influenza viruses: a strategy for optimizing live attenuated influenza vaccines. mBio 10, e02180\u201319 (2019).","journal-title":"mBio"},{"key":"37697_CR17","doi-asserted-by":"publisher","first-page":"10273","DOI":"10.1128\/JVI.00919-15","volume":"89","author":"M Zheng","year":"2015","unstructured":"Zheng, M. et al. An A14U substitution in the 3\u2019 noncoding region of the M segment of viral RNA supports replication of influenza virus with an NS1 deletion by modulating alternative splicing of M segment mRNAs. J. Virol. 89, 10273\u201310285 (2015).","journal-title":"J. Virol."},{"key":"37697_CR18","doi-asserted-by":"publisher","first-page":"103762","DOI":"10.1016\/j.ebiom.2021.103762","volume":"75","author":"R Zhou","year":"2022","unstructured":"Zhou, R. et al. Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination in mouse models. EBioMedicine 75, 103762 (2022).","journal-title":"EBioMedicine"},{"key":"37697_CR19","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S2213-2600(22)00131-X","volume":"10","author":"F Zhu","year":"2022","unstructured":"Zhu, F. et al. Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials. Lancet Respir. Med. 10, 749\u2013760 (2022).","journal-title":"Lancet Respir. Med."},{"key":"37697_CR20","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/d41586-022-02824-3","volume":"609","author":"E Waltz","year":"2022","unstructured":"Waltz, E. How nasal-spray vaccines could change the pandemic. Nature 609, 240\u2013242 (2022).","journal-title":"Nature"},{"key":"37697_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1098\/rstb.1980.0012","volume":"288","author":"RM Krug","year":"1980","unstructured":"Krug, R. M., Bouloy, M. & Plotch, S. J. RNA primers and the role of host nuclear RNA polymerase II in influenza viral RNA transcription. Philos Trans R Soc Lond B: Biol Sci 288, 359\u2013370 (1980).","journal-title":"Philos Trans R Soc Lond B: Biol Sci"},{"key":"37697_CR22","first-page":"73","volume":"386","author":"J Ayllon","year":"2015","unstructured":"Ayllon, J. & Garcia-Sastre, A. The NS1 protein: a multitasking virulence factor. Curr. Top. Microbiol. Immunol. 386, 73\u2013107 (2015).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"37697_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1146\/annurev.iy.07.040189.000343","volume":"7","author":"DM Lublin","year":"1989","unstructured":"Lublin, D. M. & Atkinson, J. P. Decay-accelerating factor: biochemistry, molecular biology, and function. Annu. Rev. Immunol. 7, 35\u201358 (1989).","journal-title":"Annu. Rev. Immunol."},{"key":"37697_CR24","doi-asserted-by":"publisher","first-page":"eabm0899","DOI":"10.1126\/scitranslmed.abm0899","volume":"14","author":"HY Huang","year":"2022","unstructured":"Huang, H. Y. et al. Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal models. Sci. Transl. Med. 14, eabm0899 (2022).","journal-title":"Sci. Transl. Med."},{"key":"37697_CR25","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/s41564-020-0770-5","volume":"5","author":"A Rambaut","year":"2020","unstructured":"Rambaut, A. et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat. Microbiol. 5, 1403\u20131407 (2020).","journal-title":"Nat. Microbiol."},{"key":"37697_CR26","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41586-021-04388-0","volume":"602","author":"L Liu","year":"2022","unstructured":"Liu, L. et al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2. Nature 602, 676\u2013681 (2022).","journal-title":"Nature"},{"key":"37697_CR27","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41586-022-04594-4","volume":"604","author":"S Iketani","year":"2022","unstructured":"Iketani, S. et al. Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature 604, 553\u2013556 (2022).","journal-title":"Nature"},{"key":"37697_CR28","doi-asserted-by":"publisher","first-page":"eabj6824","DOI":"10.1126\/scitranslmed.abj6824","volume":"14","author":"C Riou","year":"2022","unstructured":"Riou, C. et al. Escape from recognition of SARS-CoV-2 variant spike epitopes but overall preservation of T cell immunity. Sci. Transl. Med. 14, eabj6824 (2022).","journal-title":"Sci. Transl. Med."},{"key":"37697_CR29","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41586-022-04460-3","volume":"603","author":"R Keeton","year":"2022","unstructured":"Keeton, R. et al. T cell responses to SARS-CoV-2 spike cross-recognize Omicron. Nature 603, 488\u2013492 (2022).","journal-title":"Nature"},{"key":"37697_CR30","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cell.2022.01.015","volume":"185","author":"A Tarke","year":"2022","unstructured":"Tarke, A. et al. SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron. Cell 185, 847\u2013859.e811 (2022).","journal-title":"Cell"},{"key":"37697_CR31","doi-asserted-by":"publisher","first-page":"100355","DOI":"10.1016\/j.xcrm.2021.100355","volume":"2","author":"A Tarke","year":"2021","unstructured":"Tarke, A. et al. Impact of SARS-CoV-2 variants on the total CD4(+) and CD8(+) T cell reactivity in infected or vaccinated individuals. Cell Rep. Med. 2, 100355 (2021).","journal-title":"Cell Rep. Med."},{"key":"37697_CR32","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","volume":"181","author":"A Grifoni","year":"2020","unstructured":"Grifoni, A. et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181, 1489\u20131501.e1415 (2020).","journal-title":"Cell"},{"key":"37697_CR33","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.cell.2022.03.022","volume":"185","author":"V Naranbhai","year":"2022","unstructured":"Naranbhai, V. et al. T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals. Cell 185, 1259 (2022).","journal-title":"Cell"},{"key":"37697_CR34","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1093\/cid\/ciaa644","volume":"71","author":"JF Chan","year":"2020","unstructured":"Chan, J. F. et al. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Clin. Infect. Dis. 71, 2428\u20132446 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"37697_CR35","doi-asserted-by":"publisher","unstructured":"Yuan, S. et al. Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters. Science, eabn8939, https:\/\/doi.org\/10.1126\/science.abn8939 (2022).","DOI":"10.1126\/science.abn8939"},{"key":"37697_CR36","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1126\/science.abl9463","volume":"374","author":"J Zhang","year":"2021","unstructured":"Zhang, J. et al. Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant. Science 374, 1353\u20131360 (2021).","journal-title":"Science"},{"key":"37697_CR37","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-022-04442-5","volume":"603","author":"H Shuai","year":"2022","unstructured":"Shuai, H. et al. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron. Nature 603, 693\u2013699 (2022).","journal-title":"Nature"},{"key":"37697_CR38","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","volume":"608","author":"Y Cao","year":"2022","unstructured":"Cao, Y. et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature 608, 593\u2013602 (2022).","journal-title":"Nature"},{"key":"37697_CR39","doi-asserted-by":"publisher","first-page":"eabk3445","DOI":"10.1126\/scitranslmed.abk3445","volume":"14","author":"MC Maher","year":"2022","unstructured":"Maher, M. C. et al. Predicting the mutational drivers of future SARS-CoV-2 variants of concern. Sci. Transl. Med. 14, eabk3445 (2022).","journal-title":"Sci. Transl. Med."},{"key":"37697_CR40","doi-asserted-by":"publisher","first-page":"eabq4411","DOI":"10.1126\/science.abq4411","volume":"376","author":"P Elliott","year":"2022","unstructured":"Elliott, P. et al. Twin peaks: The Omicron SARS-CoV-2 BA.1 and BA.2 epidemics in England. Science 376, eabq4411 (2022).","journal-title":"Science"},{"key":"37697_CR41","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1126\/science.abg9857","volume":"373","author":"FE Lund","year":"2021","unstructured":"Lund, F. E. & Randall, T. D. Scent of a vaccine. Science 373, 397\u2013399 (2021).","journal-title":"Science"},{"key":"37697_CR42","doi-asserted-by":"publisher","unstructured":"Liew, F. et al. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination. EBioMedicine 104402, https:\/\/doi.org\/10.1016\/j.ebiom.2022.104402 (2022).","DOI":"10.1016\/j.ebiom.2022.104402"},{"key":"37697_CR43","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1073\/pnas.1620194114","volume":"114","author":"A Pizzolla","year":"2017","unstructured":"Pizzolla, A. et al. Nasal-associated lymphoid tissues (NALTs) support the recall but not priming of influenza virus-specific cytotoxic T cells. Proc. Natl. Acad. Sci. USA 114, 5225\u20135230 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"37697_CR44","doi-asserted-by":"publisher","first-page":"eaam6970","DOI":"10.1126\/sciimmunol.aam6970","volume":"2","author":"A Pizzolla","year":"2017","unstructured":"Pizzolla, A. et al. Resident memory CD8(+) T cells in the upper respiratory tract prevent pulmonary influenza virus infection. Sci. Immunol. 2, eaam6970 (2017).","journal-title":"Sci. Immunol."},{"key":"37697_CR45","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.immuni.2022.04.013","volume":"55","author":"RC Mettelman","year":"2022","unstructured":"Mettelman, R. C., Allen, E. K. & Thomas, P. G. Mucosal immune responses to infection and vaccination in the respiratory tract. Immunity 55, 749\u2013780 (2022).","journal-title":"Immunity"},{"key":"37697_CR46","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.cell.2022.02.005","volume":"185","author":"S Afkhami","year":"2022","unstructured":"Afkhami, S. et al. Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2. Cell 185, 896\u2013915.e819 (2022).","journal-title":"Cell"},{"key":"37697_CR47","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1093\/infdis\/jiy703","volume":"219","author":"R Rudraraju","year":"2019","unstructured":"Rudraraju, R., Mordant, F. & Subbarao, K. How live attenuated vaccines can inform the development of broadly cross-protective influenza vaccines. J. Infect. Dis. 219, S81\u2013S87 (2019).","journal-title":"J. Infect. Dis."},{"key":"37697_CR48","doi-asserted-by":"publisher","first-page":"6295","DOI":"10.1128\/JVI.02381-05","volume":"80","author":"A Fernandez-Sesma","year":"2006","unstructured":"Fernandez-Sesma, A. et al. Influenza virus evades innate and adaptive immunity via the NS1 protein. J. Virol. 80, 6295\u20136304 (2006).","journal-title":"J. Virol."},{"key":"37697_CR49","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.tim.2017.12.006","volume":"26","author":"C Klemm","year":"2018","unstructured":"Klemm, C., Boergeling, Y., Ludwig, S. & Ehrhardt, C. Immunomodulatory nonstructural proteins of Influenza A viruses. Trends Microbiol. 26, 624\u2013636 (2018).","journal-title":"Trends Microbiol."},{"key":"37697_CR50","doi-asserted-by":"publisher","first-page":"10293","DOI":"10.1128\/JVI.01131-12","volume":"86","author":"N Pica","year":"2012","unstructured":"Pica, N., Langlois, R. A., Krammer, F., Margine, I. & Palese, P. NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge. J. Virol. 86, 10293\u201310301 (2012).","journal-title":"J. Virol."},{"key":"37697_CR51","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1128\/JVI.01317-09","volume":"84","author":"SN Mueller","year":"2010","unstructured":"Mueller, S. N., Langley, W. A., Carnero, E., Garcia-Sastre, A. & Ahmed, R. Immunization with live attenuated influenza viruses that express altered NS1 proteins results in potent and protective memory CD8+ T-cell responses. J. Virol. 84, 1847\u20131855 (2010).","journal-title":"J. Virol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37697-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37697-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37697-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T11:03:32Z","timestamp":1681297412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37697-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["37697"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-37697-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1880060\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,12]]},"assertion":[{"value":"21 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that the University of Hong Kong has filed patents on work related to the generation and application of DelNS1 live attenuated influenza vaccines and the associated platform, with H.C., P.W., and K-Y.Y. included as co-inventors. There is no restriction on the publication of data. The other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2081"}}